CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: (3,4-dihydroxyphenyl)acetic acid
Accession: CHEBI:41941
browse the term
Definition: A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
Synonyms: related_synonym: 2-(3,4-DIHYDROXYPHENYL)ACETIC ACID; 3,4-dihydroxyphenylacetic acid; Formula=C8H8O4; InChI=1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12); InChIKey=CFFZDZCDUFSOFZ-UHFFFAOYSA-N; SMILES=OC(=O)Cc1ccc(O)c(O)c1; dopacetic acid; homoprotocatechuic acid
alt_id: CHEBI:1386; CHEBI:41936
xref: Beilstein:2211017; CAS:102-32-9; DrugBank:DB01702; Gmelin:874810; HMDB:HMDB0001336; KEGG:C01161
xref_mesh: MESH:D015102
xref: PDBeChem:DHY; PMID:11251641; PMID:11681538; PMID:11868042; PMID:15212971; PMID:15862791; PMID:18706927; PMID:19191673; PMID:22770225; PMID:4420192; Reaxys:2211017; Wikipedia:DOPAC
cyclic_relationship: is_conjugate_acid_of CHEBI:17612
G
Actb
actin, beta
affects binding multiple interactions
EXP
3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein Catechin inhibits the reaction [3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein]; epicatechin gallate inhibits the reaction [3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein]; Quercetin inhibits the reaction [3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein]
CTD
PMID:19743802
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Akt1
AKT serine/threonine kinase 1
multiple interactions increases phosphorylation
EXP
[3,4-Dihydroxyphenylacetic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein 3,4-Dihydroxyphenylacetic Acid results in increased phosphorylation of AKT1 protein
CTD
PMID:29981789
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Cartpt
CART prepropeptide
increases abundance
EXP
CARTPT protein results in increased abundance of 3,4-Dihydroxyphenylacetic Acid
CTD
PMID:15659233
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
G
Cat
catalase
multiple interactions
ISO
CAT protein inhibits the reaction [N-Methyl-3,4-methylenedioxyamphetamine results in decreased abundance of 3,4-Dihydroxyphenylacetic Acid]
CTD
PMID:11435997
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Comt
catechol-O-methyltransferase
increases methylation multiple interactions
ISO EXP
COMT protein results in increased methylation of 3,4-Dihydroxyphenylacetic Acid [tolcapone results in decreased activity of COMT protein] which results in increased abundance of 3,4-Dihydroxyphenylacetic Acid
CTD
PMID:11160877 PMID:11793163 PMID:15190105 PMID:16012872
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
3,4-Dihydroxyphenylacetic Acid results in increased expression of GSTP1 mRNA
CTD
PMID:19743802
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gys1
glycogen synthase 1
multiple interactions decreases phosphorylation
EXP
3,4-Dihydroxyphenylacetic Acid inhibits the reaction [Glucose results in increased phosphorylation of GYS1 protein] 3,4-Dihydroxyphenylacetic Acid results in decreased phosphorylation of GYS1 protein
CTD
PMID:29981789
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
G
Insr
insulin receptor
multiple interactions
EXP
3,4-Dihydroxyphenylacetic Acid inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of INSR protein]; 3,4-Dihydroxyphenylacetic Acid results in increased expression of and results in increased phosphorylation of INSR protein
CTD
PMID:29981789
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
G
Maob
monoamine oxidase B
multiple interactions
EXP
[Selegiline results in decreased activity of MAOB protein] which results in decreased abundance of 3,4-Dihydroxyphenylacetic Acid
CTD
PMID:16012872
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Nos1
nitric oxide synthase 1
multiple interactions
ISO
NOS1 protein affects the reaction [Methamphetamine results in decreased abundance of 3,4-Dihydroxyphenylacetic Acid]
CTD
PMID:11085313
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
3,4-Dihydroxyphenylacetic Acid results in increased expression of NQO1 mRNA
CTD
PMID:19743802
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases abundance
ISO
NR3C1 protein results in increased abundance of 3,4-Dihydroxyphenylacetic Acid
CTD
PMID:11226678
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Oprm1
opioid receptor, mu 1
multiple interactions
EXP
[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of 3,4-Dihydroxyphenylacetic Acid]
CTD
PMID:8884884
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
[PARP1 protein results in increased susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] which results in increased abundance of 3,4-Dihydroxyphenylacetic Acid
CTD
PMID:10318960
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Slc22a8
solute carrier family 22 member 8
multiple interactions
EXP
3,4-Dihydroxyphenylacetic Acid inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:10224140
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Snca
synuclein alpha
decreases abundance
ISO
SNCA protein mutant form results in decreased abundance of 3,4-Dihydroxyphenylacetic Acid
CTD
PMID:18622040
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Tfam
transcription factor A, mitochondrial
decreases abundance
ISO
TFAM gene mutant form results in decreased abundance of 3,4-Dihydroxyphenylacetic Acid
CTD
PMID:28595911
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
G
Aqp9
aquaporin 9
multiple interactions
ISO
AQP9 gene mutant form inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased abundance of Homovanillic Acid]
CTD
PMID:29566083
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Comt
catechol-O-methyltransferase
multiple interactions
ISO EXP
[tolcapone results in decreased activity of COMT protein] which results in decreased abundance of Homovanillic Acid
CTD
PMID:11793163 PMID:15190105 PMID:16012872
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Maob
monoamine oxidase B
multiple interactions
EXP
[Selegiline results in decreased activity of MAOB protein] which results in decreased abundance of Homovanillic Acid
CTD
PMID:16012872
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Nos1
nitric oxide synthase 1
multiple interactions
ISO
NOS1 protein affects the reaction [Methamphetamine results in decreased abundance of Homovanillic Acid]
CTD
PMID:11085313
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases abundance
ISO
NR3C1 protein results in increased abundance of Homovanillic Acid
CTD
PMID:11226678
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Oprm1
opioid receptor, mu 1
multiple interactions
EXP
[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of Homovanillic Acid]
CTD
PMID:8884884
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
[PARP1 protein results in increased susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] which results in increased abundance of Homovanillic Acid
CTD
PMID:10318960
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Sct
secretin
increases abundance
ISO
SCT protein results in increased abundance of Homovanillic Acid
CTD
PMID:16168596
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
G
Slc22a8
solute carrier family 22 member 8
multiple interactions
EXP
Homovanillic Acid inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:10224140
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Tfam
transcription factor A, mitochondrial
decreases abundance
ISO
TFAM gene mutant form results in decreased abundance of Homovanillic Acid
CTD
PMID:28595911
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
G
Vdr
vitamin D receptor
multiple interactions increases abundance
ISO
Calcitriol promotes the reaction [VDR protein results in increased abundance of Homovanillic Acid]
CTD
PMID:27450565
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all